Skip to main content

Advertisement

Rahayu Mahzam on pre-implantation genetic screening

A pilot study on pre-implantation genetic screening (PGS) has had a high attrition rate of about 72 per cent and more data is needed to determine its clinical effectiveness, said Parliamentary Secretary for Health Rahayu Mahzam in Parliament on Tuesday (Mar 2). She said MOH will try to support as many patients as possible to participate, but must proceed carefully as there is some risk to the embryo. Ms Rahayu was answering an MP’s questions on whether MOH could allow any patient regardless of prognosis to take part in the study and whether full subsidies could be considered.

Rahayu Mahzam on pre-implantation genetic screening

02 Mar 2021 10:48am
A pilot study on pre-implantation genetic screening (PGS) has had a high attrition rate of about 72 per cent and more data is needed to determine its clinical effectiveness, said Parliamentary Secretary for Health Rahayu Mahzam in Parliament on Tuesday (Mar 2). She said MOH will try to support as many patients as possible to participate, but must proceed carefully as there is some risk to the embryo. Ms Rahayu was answering an MP’s questions on whether MOH could allow any patient regardless of prognosis to take part in the study and whether full subsidies could be considered.

Advertisement

You May Also Like

Advertisement